RhumbLine Advisers’s MiMedx Group MDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.23M | Sell |
|
|||||
|
2025
Q2 | $1.12M | Buy |
|
|||||
|
2025
Q1 | $1.35M | Buy |
|
|||||
|
2024
Q4 | $1.68M | Sell |
|
|||||
|
2024
Q3 | $1.04M | Sell |
|
|||||
|
2024
Q2 | $1.29M | Sell |
|
|||||
|
2024
Q1 | $1.46M | Buy |
|
|||||
|
2023
Q4 | $1.64M | Buy |
|
|||||
|
2023
Q3 | $1.35M | Buy |
|
|||||
|
2023
Q2 | $1.19M | Buy |
|
|||||
|
2023
Q1 | $602K | Buy |
|
|||||
|
2022
Q4 | $475K | Buy |
|
|||||
|
2022
Q3 | $484K | Buy |
|
|||||
|
2022
Q2 | $561K | Buy |
|
|||||
|
2022
Q1 | $567K | Buy |
|
|||||
|
2021
Q4 | $689K | Sell |
|
|||||
|
2021
Q3 | $703K | Buy |
|
|||||
|
2021
Q2 | $1.38M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $1.55M | Sell |
|
|||||
|
2018
Q2 | $1.61M | Buy |
|
|||||
|
2018
Q1 | $1.69M | Buy |
|
|||||
|
2017
Q4 | $2.98M | Buy |
|
|||||
|
2017
Q3 | $2.43M | Buy |
|
|||||
|
2017
Q2 | $2.97M | Buy |
|
|||||
|
2017
Q1 | $1.89M | Buy |
|
|||||
|
2016
Q4 | $1.26M | Buy |
|
|||||
|
2016
Q3 | $1.17M | Buy |
|
|||||
|
2016
Q2 | $1.05M | Sell |
|
|||||
|
2016
Q1 | $1.16M | Buy |
|
|||||
|
2015
Q4 | $1.21M | Buy |
|
|||||
|
2015
Q3 | $1.1M | Buy |
|
|||||
|
2015
Q2 | $1.28M | Buy |
|
|||||
|
2015
Q1 | $924K | Buy |
|
|||||
|
2014
Q4 | $861K | Sell |
|
|||||
|
2014
Q3 | $550K | Sell |
|
|||||
|
2014
Q2 | $550K | Buy |
|
|||||
|
2014
Q1 | $460K | Sell |
|
|||||
|
2013
Q4 | $674K | Buy |
|
|||||
|
2013
Q3 | $317K | Buy |
|
|||||
|
2013
Q2 | $521K | Buy |
|